Contact our Pharma Partnering Team

Partnering with Pharma

As a pioneer in healthcare we are committed to driving groundbreaking scientific and technological advances that have the potential to transform the lives of patients worldwide. But we can’t accomplish this on our own. Only by partnering with the brightest minds in science and healthcare can we serve the needs of patients.

“A great idea is a great idea, no matter where it comes from.”

At Roche and Genentech, we are leveraging our unique company structure and culture to build deep and long-lasting connections with our partners to translate pioneering science into breakthroughs for patients.

As the only company combining pharma, diagnostics solutions, as well as cutting-edge tech and data capabilities under one roof, we are uniquely positioned to improve patients' lives by better diagnosing, treating and ultimately preventing devastating diseases.

We have a long history of driving some of the biggest breakthroughs in science and medicine - reshaping treatment paradigms to help people with devastating and difficult-to-treat diseases. Our world-class scientific talent, spread globally across the Roche Group’s autonomous R&D units, is pursuing innovation in diverse ways.

We strongly believe in the fundamental value of partnerships and team up with trail blazing partners to discover and develop truly revolutionizing treatments. We are eager to build lasting and fully symbiotic partnerships where both parties can bring in their strengths and benefit from each other in the most optimal way to deliver new solutions for patients.

Presentation

We are focusing on partnerships that have the potential to make a significant difference for patients. Our ideal partner shares our passion for breakthrough science and the vision to make a lasting contribution to people’s health.

We strongly believe that the key elements to a successful and lasting partnership are trust, shared values and openness. To revolutionise today’s standard of care, we are looking for best or first in class innovation in the following therapy areas:

View all areas of interest

We use an efficient four-step process to manage lasting partnerships from the first conversations to a long-term collaboration. At each step we can modify and tailor the relationship and create the structure for collaboration together, ensuring it meets both parties’ needs and creates a win-win situation for all involved. We bring in our best scientists and commercial experts early on to create deep and lasting partnerships that go beyond the initial deal. And we tap into the broad range of capabilities the Roche Group has to offer that can help patients from prevention, to diagnosis through treatment.

Partnering with Roche & Genentech is not your typical corporate experience. Our success in bringing breakthrough treatments to patients today is the result of pioneering partnerships that are built on trust, flexibility, shared values and a passion for advancing science to make a lasting contribution for people’s health.

See more stories

120 of our colleagues around the globe are building the bridge between brilliant ideas coming from within Roche and those coming from the world around us. Our global footprint with offices in Basel, South San Francisco, Boston, Cambridge, Shanghai and Tokyo offers speed, flexibility and accessibility.

If you have an opportunity for collaboration or an interesting technology, or if you have an asset in one of our areas of interest, we would like to hear from you.

Contact our Pharma Partnering Team

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2022Privacy policyLegal statement